Several studies analyzed under a new systematic review have shown that coronary heart disease patients with Angina pectoris benefit a lot by taking ‘Tongxinluo’, a Chinese herbal medicine widely used in Asia, along with their conventional medicines for the disease. Tongxinluo is prepared from herbs and insects, which are powdered together and then enclosed in capsules. Taixiang, an associate professor at Sichuan University, West China Hospital, in Chengdu, Sichuan, and other co-authors of this review said that they felt a “social responsibility” to investigate possible clinical benefits of Tongxinluo, after seeing the popularity of this medicine among cardiovascular patients in Asia. The findings of their review appear in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates research in all aspects of health care.

Angina refers to the chest pain caused by lack of blood and oxygen supply to the heart, in patients suffering from coronary heart diseases. It is usually described as pressure, heaviness, squeezing, burning or choking sensation in the heart, which lasts for roughly 1 to 10 minutes. Angina is a symptom of coronary heart diseases and if left untreated it may worsen to myocardial infarction (heart attack). Many studies analyzed in this review indicate that patients with unstable Angina, who took Tongxinluo along with their conventional pharmacological treatment, showed good results in electrocardiogram (ECG or EKG), which is used to screen and diagnose cardiovascular diseases.

Read more of this story….

Be Sociable, Share!